Paper
Organic & Biomolecular Chemistry
in situ generated β-ketoenamines, is reported. The methodo-
logy is an alternative to the Hantzsch or Knorr pyrrole syn-
thesis which is not limited to compounds bearing an electron-
withdrawing substituent. If at least one aryl group could con-
veniently be introduced, since the formation of sufficiently
stable enamines derived from phenylacetaldehyde or its substi-
tuted derivatives proved to be necessary, it was possible to
obtain compounds with one alkyl group at position 3. The
method could be extended to the synthesis of 2,4-diaryl-
pyrroles either by reversing the order of introduction of the reac-
tants or using an unprecedented rearrangement. Simplified
analogs of halitulin were prepared using the present methodo-
8 (a) I. S. Young, P. D. Thornton and A. Thompson, Nat. Prod.
Rep., 2010, 27, 1801–1839; (b) S. Thirumalairajan,
B. M. Pearce and A. Thompson, Chem. Commun., 2010, 46,
1797–1812. For the biological formation of pyrroles, see:
(c) C. T. Walsh, S. Garneau-Tsodikova and A. R. Howard-
Jones, Nat. Prod. Rep., 2006, 23, 517–531.
9 (a) D. Davidson, J. Org. Chem., 1938, 3, 361–364;
(b) H. J. Roth, H. George, F. Assadi and H. J. Rimek, Angew.
Chem., Int. Ed., 1968, 7, 946; (c) A. Goel, N. Agarwal,
F. V. Singh, A. Sharon, P. Tiwari, M. Dixit, R. Pratap,
A. K. Srivastava, P. R. Maulik and V. J. Ram, Bioorg. Med.
Chem. Lett., 2004, 14, 1089–1092.
logy and the cytotoxicity of some of the products obtained was 10 X. Wan, D. Xing, Z. Fang, B. Li, F. Zhao, K. Zang,
studied. Compound 25, with two nitrocatechol moieties as
L. Yang and Z. Shi, J. Am. Chem. Soc., 2006, 128, 12046–
substituents of the pyrrole ring and a 3-(azatricyclodecan-1yl)-
12047.
propyl group on the nitrogen, was found to be the derivative 11 (a) Q. Li, A. Fan, Z. Lu, Y. Cui, W. Lin and Y. Jia, Org. Lett.,
with the highest cytotoxic activity of the series, the mechanism
of which involved in part an autophagic response, without any
caspase-dependent cell death mechanism. This compound
might be a useful lead for anticancer drug development.
2010, 12, 4066–4069; for an application to natural products
synthesis, see: (b) Q. Li, J. Jiang, A. Fan, Y. Cui and Y. Jia,
Org. Lett., 2011, 13, 312–315; see also: (c) F. Dagorn,
L.-H. Yan, E. Gravel, K. Leblanc, A. Maciuk and E. Poupon,
Tetrahedron Lett., 2011, 52, 3523–3526.
12 L. E. Fisher and J. M. Muchowski, Org. Prep. Proced. Int.,
1990, 22, 399–484.
13 H. G. Aurich, J. Eidel and M. Schmidt, Chem. Ber., 1986,
119, 36–49.
14 M. Caldarelli, J. Habermann and S. V. Ley, J. Chem. Soc.,
Perkin Trans. 1, 1999, 107–110.
15 D. R. Dragoli, M. T. Burdett and J. A. Ellman, J. Am. Chem.
Soc., 2001, 123, 10127–10128.
Notes and references
1 (a) J.-C. Wypych, T. M. Nguyen, P. Nuhant, M. Bénéchie
and C. Marazano, Angew. Chem., Int. Ed., 2008, 47, 5418–
5421; (b) I. Sinigaglia, T. M. Nguyen, J.-C. Wypych,
B. Delpech and C. Marazano, Chem.–Eur. J., 2010, 16, 3594–
3597.
16 (a) M. R. Heinrich, Y. Kashman, P. Spiteller and
W. Steglich, Tetrahedron, 2001, 57, 9973–9978;
(b) M. R. Heinrich and W. Steglich, Tetrahedron Lett., 2001,
42, 3287–3289; (c) M. G. Banwell, A. M. Bray, A. J. Edwards
and D. J. Wong, New J. Chem., 2001, 25, 1347–1350;
(d) J.-F. Zheng, L.-R. Jin and P.-Q. Huang, Org. Lett., 2004, 6,
1139–1142.
2 J. E. Baldwin and R. C. Whitehead, Tetrahedron Lett., 1992,
33, 2059–2062.
3 H. Fan, J. Peng, M. T. Hamann and J.-F. Hu, Chem. Rev.,
2008, 108, 264–287.
4 Y. Kashman, G. Koren-Goldshlager, M. D. G. Gravalos and
M. Schleyer, Tetrahedron Lett., 1999, 40, 997–1000.
5 M. R. Heinrich, W. Steglich, M. G. Banwell and
Y. Kashman, Tetrahedron, 2003, 59, 9239–9247.
6 (a) V. F. Ferreira, M. C. B. V. de Souza, A. C. Cunha,
L. O. R. Pereira and M. L. G. Ferreira, Org. Prep. Proced. Int.,
2001, 33, 411–454; (b) C. Schmuck and D. Rupprecht, Syn-
thesis, 2007, 3095–3110; (c) V. Estévez, M. Villacampa and
J. C. Menéndez, Chem. Soc. Rev., 2010, 39, 4402–4421;
(d) T. Tsuchimoto, Chem.–Eur. J., 2011, 17, 4064–4075. For
a recent variant of the Hantzsch pyrrole synthesis, see:
(e) V. Estévez, M. Villacampa and J. C. Menéndez, Chem.
Commun., 2013, 49, 591–593.
7 (a) F. Bellina and R. Rossi, Tetrahedron, 2006, 62, 7213–
7256. For the preparation of 1-(3,4-dimethoxyphenylethyl)-
3,4-diphenyl-1H-pyrrole by the Kumada–Corriu cross-coup-
ling reaction of the 3,4-diiodinated pyrrole with phenyl-
magnesium bromide, see: (b) L. C. Axford, K. E. Holden,
K. Hasse, M. C. Banwell, W. Steglich, J. Wagler and
A. C. Willis, Aust. J. Chem., 2008, 61, 80–93.
17 G. Koren-Goldshlager, Y. Kashman and M. Schleyer, J. Nat.
Prod., 1998, 61, 282–284.
18 (a) D. E. Williams, P. Lassota and R. J. Andersen, J. Org.
Chem., 1998, 63, 4838–4841; (b) D. E. Williams, K. S. Craig,
B. Patrick, L. M. McHardy, R. van Soest, M. Roberge and
R. J. Andersen, J. Org. Chem., 2002, 67, 245–258.
19 F. von Nussbaum, S. Schumann and W. Steglich, Tetra-
hedron, 2001, 57, 2331–2335.
20 (a) J. R. Carson and N. M. Davis, J. Org. Chem., 1981, 46,
839–841; (b) B. A. Trofimova, O. V. Petrova, L. N. Sobenina,
I. A. Ushakov, A. I. Mikhaleva, Y. Y. Rusakov and
L. B. Krivdin, Tetrahedron Lett., 2006, 47, 3645–3648;
(c) J.-H. Mirebeau, M. Haddad, M. Henry-Ellinger,
G. Jaouen, J. Louvel and F. Le Bideau, J. Org. Chem., 2009,
74, 8890–8892.
21 M. R. Heinrich and W. Steglich, Tetrahedron, 2003, 59,
9231–9237.
1524 | Org. Biomol. Chem., 2014, 12, 1518–1524
This journal is © The Royal Society of Chemistry 2014